Sanpaolo IMI Fondi Chiusi provides entrepreneur expertise on issues of strategic consulting and financial support.
Business Model: Consulting
Revenue: $10M
Employees: 2-10
Address:
City:
State:
Zip:
Country:
The activity of the SGR is addressed solely to the investment in risk capital for small and medium-sized enterprises, in support of their development, their aggregation and reorganization, with the goal of consistently providing the entrepreneur expertise on issues of strategic consulting and financial support needed in the evolution of his business. IMI Fondi Chiusi SGR SpA is 100% owned by Intesa Sanpaolo S.p.A through IMI Investimenti S.p.A. The company is headquartered in Bologna and operating offices in Milan, Rome and Naples. IMI Fondi Chiusi SGR SpA is a member AIFI (Italian Association of Institutional Investors in Venture Capital) and EVCA (European Private Equity and Venture Capital Association). The SGR adheres to the Protocol of Autonomy AIFI. IMI Fondi Chiusi SGR Italian Stock Exchange and collaborate for the promotion of the Service for the development of Italian SMEs (email: [email protected])
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2016 | Mosaicoon | Series B | 0 |
12/2005 | TISSUELAB | Venture Round | 0 |
5/2010 | Tethis S.p.A | Venture Round | - |
6/2014 | T&a;P S.p.A. | Venture Round | - |
7/2007 | TISSUELAB | Venture Round | 0 |
4/2012 | SVAS Biosana | Venture Round | 0 |
3/2010 | Menarini Silicon Biosystems | Venture Round | 0 |
5/2016 | Mosaicoon | Series B | 0 |
6/2014 | T&a;P S.p.A. | Venture Round | - |
4/2012 | SVAS Biosana | Venture Round | 0 |
5/2010 | Tethis S.p.A | Venture Round | - |
3/2010 | Menarini Silicon Biosystems | Venture Round | 0 |
7/2007 | TISSUELAB | Venture Round | 0 |
12/2005 | TISSUELAB | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|